| Patent No. | Patent Title: |
| 8188232 | Compositions and methods for modulating lymphocyte activity |
| 8188238 | Recombinantly produced antibody |
| 8187598 | Methods of treating cancer by administering antibodies to CD200 |
| 8178093 | Method for treating infectious disease using monoclonal antibodie... |
| 8173603 | Methods of using BTL-II proteins |
| 8173123 | Methods of treating colitis involving IL-13 and NK-T cells |
| 8168179 | Treatment method using anti-PD-L1 antibody |
| 8168759 | Compositions monovalent for CD28 binding and methods of use |
| 8168182 | Method for treating erectile dysfunction |
| 8168757 | PD-1 binding proteins |
| 8163550 | Enhancement of immune responses by 4-1BB-binding agents |
| 8163546 | Mammalian cell-based immunoglobulin display libraries |
| 8158386 | Method for producing human antibodies with properties of agonist,... |
| 8158767 | Polypeptides and methods for making the same |
| 8153595 | B7-DC variants immunogenic compositions and methods of use thereo... |
| 8153433 | Mammalian cell lines for increasing longevity and protein yield f... |
| 8153124 | Method for treating cancer using monoclonal antibodies |
| 8153123 | Method for restoring dendritic cell populations |
| 8148332 | Method for treating a rheumatic disease using a soluble TLA4 mole... |
| 8147829 | Anti-IGR-1R antibodies and uses thereof |
| 8143379 | Human monoclonal antibodies to CTLA-4 |
| 8142778 | Methods of treatment using CTLA-4 antibodies |
| 8137667 | Fully human antibodies against human 4-1BB |
| 8129126 | Use of the 4-1BB receptor for identifying and/or separating activ... |
| 8129347 | Methods for treating autoimmune diseases using B7-H4 polypeptides... |
| 8128927 | Methods of using TGF-β 1 binding compositions |
| 8124078 | Method for treating idiopathic thrombocytopenic purpura using mon... |
| 8119129 | Combination of anti-CTLA4 antibody with dasatinib for the treatme... |
| 8119604 | Polypeptide formulation |
| 8114845 | Compositions of PD-1 antagonists and methods of use |
| 8110665 | Pharmaceutical composition comprising an immunoglobulin FC region... |
| 8101175 | Methods of treating OX40 mediated recall immune responses using O... |
| 8097249 | Use of PD-L3 proteins and PD-L3 specific antibodies or antibody f... |
| 8097598 | Porcine CTLA-4 for xenograft-specific immunosuppression |
| 8088905 | Nucleic acids encoding antibodies against PD-1 |
| 8084217 | CD161 ligand, pilar, for modulating activation and proliferation ... |
| 8080636 | BSL3 antibodies |
| 8075884 | Antibodies to OX-2/CD200 and uses thereof |
| 8076140 | Mammalian cell lines for increasing longevity and protein yield f... |
| 8071336 | Antibody-based therapeutics with enhanced ADCC activity |
Quotables 
PatentStorm News
